Your browser doesn't support javascript.
loading
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
Sugimoto, Naoshi; Kanda, Junya; Nakamura, Sou; Kitano, Toshiyuki; Hishizawa, Masakatsu; Kondo, Tadakazu; Shimizu, Shin; Shigemasa, Akiko; Hirai, Hideyo; Arai, Yasuyuki; Minami, Manabu; Tada, Harue; Momose, Dai; Koh, Ki-Ryang; Nogawa, Masayuki; Watanabe, Naohide; Okamoto, Shinichiro; Handa, Makoto; Sawaguchi, Akira; Matsuyama, Nobuki; Tanaka, Mitsunobu; Hayashi, Tomoya; Fuchizaki, Akihiro; Tani, Yoshihiko; Takaori-Kondo, Akifumi; Eto, Koji.
Afiliação
  • Sugimoto N; Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Kanda J; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Nakamura S; Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Kitano T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Hishizawa M; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Kondo T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Shimizu S; Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Shigemasa A; Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Hirai H; Department of Clinical Laboratory Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Arai Y; Department of Clinical Laboratory Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Minami M; Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Kyoto, Japan.
  • Tada H; Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Kyoto, Japan.
  • Momose D; Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Koh KR; Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Nogawa M; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Watanabe N; Division of Hematology, Keio University School of Medicine, Tokyo, Japan.
  • Okamoto S; Division of Hematology, Keio University School of Medicine, Tokyo, Japan.
  • Handa M; Center for Transfusion Medicine & Cell Therapy, Keio University School of Medicine, Tokyo, Japan.
  • Sawaguchi A; Department of Anatomy, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Matsuyama N; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Tanaka M; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Hayashi T; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Fuchizaki A; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Tani Y; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Takaori-Kondo A; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Eto K; Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Blood ; 140(22): 2398-2402, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36112961
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão